JPMorgan Chase & Co’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.8K | Buy |
7,030
+5,979
| +569% | +$4.08K | ﹤0.01% | 5543 |
|
2025
Q1 | $958 | Sell |
1,051
-11
| -1% | -$10 | ﹤0.01% | 5757 |
|
2024
Q4 | $1.16K | Buy |
1,062
+158
| +17% | +$172 | ﹤0.01% | 5660 |
|
2024
Q3 | $685 | Hold |
904
| – | – | ﹤0.01% | 5701 |
|
2024
Q2 | $1.12K | Sell |
904
-14,522
| -94% | -$18K | ﹤0.01% | 5581 |
|
2024
Q1 | $29.2K | Sell |
15,426
-7,015
| -31% | -$13.3K | ﹤0.01% | 5143 |
|
2023
Q4 | $59.2K | Hold |
22,441
| – | – | ﹤0.01% | 4965 |
|
2023
Q3 | $51.6K | Sell |
22,441
-5,140
| -19% | -$11.8K | ﹤0.01% | 4903 |
|
2023
Q2 | $101K | Buy |
27,581
+27,542
| +70,621% | +$101K | ﹤0.01% | 4634 |
|
2023
Q1 | $0 | Hold |
39
| – | – | ﹤0.01% | 5845 |
|
2022
Q4 | $0 | Hold |
39
| – | – | ﹤0.01% | 5621 |
|
2022
Q3 | $0 | Hold |
39
| – | – | ﹤0.01% | 5559 |
|
2022
Q2 | $0 | Sell |
39
-14,552
| -100% | – | ﹤0.01% | 5628 |
|
2022
Q1 | $71K | Buy |
14,591
+2,546
| +21% | +$12.4K | ﹤0.01% | 4878 |
|
2021
Q4 | $136K | Buy |
12,045
+510
| +4% | +$5.76K | ﹤0.01% | 4707 |
|
2021
Q3 | $168K | Sell |
11,535
-54
| -0.5% | -$786 | ﹤0.01% | 4493 |
|
2021
Q2 | $135K | Buy |
11,589
+427
| +4% | +$4.97K | ﹤0.01% | 4666 |
|
2021
Q1 | $136K | Sell |
11,162
-1,963
| -15% | -$23.9K | ﹤0.01% | 4582 |
|
2020
Q4 | $165K | Buy |
13,125
+2,399
| +22% | +$30.2K | ﹤0.01% | 4198 |
|
2020
Q3 | $165K | Buy |
10,726
+1,384
| +15% | +$21.3K | ﹤0.01% | 3821 |
|
2020
Q2 | $229K | Buy |
9,342
+2,778
| +42% | +$68.1K | ﹤0.01% | 3617 |
|
2020
Q1 | $93K | Sell |
6,564
-250
| -4% | -$3.54K | ﹤0.01% | 3962 |
|
2019
Q4 | $108K | Buy |
6,814
+387
| +6% | +$6.13K | ﹤0.01% | 3997 |
|
2019
Q3 | $54K | Buy |
6,427
+1,471
| +30% | +$12.4K | ﹤0.01% | 4223 |
|
2019
Q2 | $38K | Buy |
4,956
+643
| +15% | +$4.93K | ﹤0.01% | 4360 |
|
2019
Q1 | $33K | Sell |
4,313
-203
| -4% | -$1.55K | ﹤0.01% | 4358 |
|
2018
Q4 | $21K | Buy |
4,516
+422
| +10% | +$1.96K | ﹤0.01% | 4487 |
|
2018
Q3 | $37K | Buy |
4,094
+504
| +14% | +$4.56K | ﹤0.01% | 4446 |
|
2018
Q2 | $43K | Buy |
3,590
+1,795
| +100% | +$21.5K | ﹤0.01% | 4359 |
|
2018
Q1 | $25K | Buy |
+1,795
| New | +$25K | ﹤0.01% | 4351 |
|